- Browse by Author
Browsing by Author "Kooreman, Harold"
Now showing 1 - 10 of 22
Results Per Page
Sort Options
Item Adoption of Health Information Technology Among US Nursing Facilities(Elsevier, 2018-12-19) Vest, Joshua R.; Jung, Hye-Young; Wiley, Kevin; Kooreman, Harold; Pettit, Lorren; Unruh, Mark A.; Health Policy and Management, School of Public HealthObjectives: Nursing facilities have lagged behind in the adoption interoperable health information technology (i.e. technologies that allow the sharing and use of electronic patient information between different information systems). The objective of this study was to estimate the nationwide prevalence of electronic health record (EHR) adoption among nursing facilities and to identify the factors associated with adoption. Design: Cross-sectional survey. Setting & participants: We surveyed members of the Society for Post-Acute & Long-Term Care Medicine (AMDA) about their organizations’ health information technology usage and characteristics. Measurements: Using questions adopted from existing instruments, the survey measured nursing home’s EHR adoption, the ability to send, receive, search and integrate electronic information, as well as barriers to usage. Additionally, we linked survey responses to public use secondary data sources to construct measurements for eight determinants known to be associated with organizational adoption: innovativeness, functional differentiation, role specialization, administrative intensity, professionalism, complexity, technical knowledge resources and slack resources. A series of regression models estimated the association between potential determinants and technology adoption. Results: 84% of nursing facilities reported using an EHR. After controlling for all other factors, respondents who characterized their organization as more innovative had more than 6 times the odds (adjusted odds ratio = 6.39; 95%CI = 2.69, 15.21) of adopting an EHR. Organization innovativeness was also associated with an increased odds of being able to send, integrate, and search for electronic information. The most commonly identified barrier to sharing clinical information among nursing facilities with an EHR was a reported absence of interoperability (57%). Conclusions/Implications: An organizational culture that fosters innovation and awareness campaigns by professional societies may facilitate further adoption and effective use of technology. This will be increasingly important as policymakers continue to emphasize the use of EHRs and interoperability to improve the quality of care in nursing facilities.Item Drivers of Substance Misuse and Addiction in Indiana(Fairbanks School of Public Health, 2023-02) Greene, Marion; Kooreman, Harold; Kampman, HaleighSubstance use continues to be a significant concern in Indiana. Misuse of alcohol and/or illicit drugs can lead to numerous negative consequences, often affecting a person’s physical and mental health, relationships with family and friends, and their ability to hold a job. As drug use progresses into dependence and addiction, there is an increased risk that individuals become involved with the justice system. Arrests and incarcerations can occur for using illicit drugs, driving under the influence of a substance, or for engaging in drug-related criminal activities such as dealing. Furthermore, persons addicted to drugs, especially opioids and sedative-hypnotics, are at risk for accidental or intentional overdose, which can be fatal. These consequences not only affect the individual, but also have a considerable impact on their families and the community.Item The Impact of the COVID-19 Pandemic on Behavioral Health in Indiana(The Center for Health Policy, 2021-06-01) Kooreman, Harold; Gutta, Jyotsna; Bandali, Elhaam; Greene, Marion S.As of January 2021, the Johns Hopkins Coronavirus Resource Center has confirmed more than 20 million SARS-CoV-2 cases and over 350,000 deaths in the United States alone and 100 million cases and more than 2 million deaths globally. As of December 31, 2020, over half a million Hoosiers had tested positive for COVID-19 and more than 8,000 had died as a result of complications from the disease. This report is a review on the impact the COVID-19 pandemic had (and has) on the mental and behavioral health of Hoosiers. Specifically, we reviewed pandemic-related stress on children, parents, and the elderly; substance use, misuse, and overdose deaths; mental health concerns; suicide; domestic violence; and child abuse and neglect. The current report is a summary of findings. It provides a snapshot in time. Data and conclusions were relevant and timely at the time the report was produced.Item Injection Drug Use in Indiana: A Major Risk for HIV Transmission(Richard M. Fairbanks School of Public Health, 2016-01) Kooreman, Harold; Greene, MarionIllicit drug use is a significant public health issue. In 2014, approximately 27 million people, or 10.2 percent of the United States population 12 years of age or older, were currently using some type of illicit substance, while 7.1 million people 12 years of age or older could be classified as either abusing or being dependent on an illicit drug.Item Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey(IU Richard M Fairbanks School of Public Health, 2014-06) Kooreman, Harold; Carnes, Neal; Wright, Eric R.The Center for Health Policy in collaboration with the Indiana Professional Licensing Agency and the State Prescription Drug Abuse Prevention Task Force’s Education Committee developed a web-based survey to gather information on prescribers’ and dispensers’ knowledge, use, and opinions of INSPECT as well as to assess prescribers’ and dispensers’ attitudes and beliefs about prescribing and dispensing opioids. Key findings suggest that both providers and dispensers are strongly supportive and frequent users of the INSPECT program; the majority of users believe INSPECT is generally effective and a valuable tool in state-wide efforts to reduce the misuse, abuse, and diversion of prescription drugs.Item Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey(Richard M. Fairbanks School of Public Health, 2014-06) Kooreman, Harold; Carnes, Neal; Wright, EricThe Center for Health Policy in collaboration with the Indiana Professional Licensing Agency and the State Prescription Drug Abuse Prevention Task Force Education Committee developed a web-based survey to gather information on prescribers and dispensers knowledge, use, and opinions of INSPECT as well as to assess prescribers and dispensers attitudes and beliefs about prescribing and dispensing opioids. Key findings suggest that both providers and dispensers are strongly supportive and frequent users of the INSPECT program; the majority of users believe INSPECT is generally effective and a valuable tool in state-wide efforts to reduce the misuse, abuse, and diversion of prescription drugs.Item LaPorte County Opioid Addiction Needs Assessment(Richard M. Fairbanks School of Public Health, 2018) Greene, Marion; Kooreman, Harold; Vest, Joshua; Balio, CaseyThe opioid epidemic continues to affect the lives of many Americans. Paralleling the rise in prescription opioid (pain reliever) sales over the past two decades, the country also experienced an increase in opioid-related morbidity and mortality. Between 2000 and 2015, more than half a million Americans died from drug overdoses, the majority of which were attributable to opioids. The costs, in terms of human suffering and economic impact, are considerable. Based on findings from the LaPorte County survey and key informant interviews that were conducted in the community, respondents cited lack of or limited access to treatment services, especially detoxification, inpatient services, and medication-assisted treatment, as a major challenge in dealing with the epidemic. Furthermore, socio-economic factors, such as poverty and unemployment, and limited awareness or acceptance of the problem within the larger community, together with insufficient funding to address the problem, were described as contributing factors.Item Medicated-Assisted Treatment in Indiana(The Center for Health Policy, 2019-03-01) Kooreman, HaroldOpioid misuse and addiction continues to affect many Americans. Medication-assisted treatment (MAT) using methadone, buprenorphine, or extended-release naltrexone in combination with behavioral therapy is the most effective intervention for opioid use disorders (OUDs). Despite its effectiveness, methadone to treat OUDs is not widely available. Buprenorphine is more accessible, as it can be prescribed by medical doctors, nurse practitioners, and physician assistants who have received specialized training and obtained a waiver from the DEA. Naltrexone is a non-narcotic and can be prescribed by any healthcare professional who has prescription privileges.Item Medicated-Assisted Treatment in Indiana(Richard M. Fairbanks School of Public Health, 2019-03) Kooreman, HaroldOpioid misuse and addiction continues to affect many Americans. Medication-assisted treatment (MAT) using methadone, buprenorphine, or extended-release naltrexone in combination with behavioral therapy is the most effective intervention for opioid use disorders (OUDs). Despite its effectiveness, methadone to treat OUDs is not widely available. Buprenorphine is more accessible, as it can be prescribed by medical doctors, nurse practitioners, and physician assistants who have received specialized training and obtained a waiver from the DEA. Naltrexone is a non-narcotic and can be prescribed by any healthcare professional who has prescription privileges.Item Opioid Overdoses in Indiana: A Closer Look at Opioid Type(The Center for Health Policy, 2018-06-01) Kooreman, HaroldThe misuse of prescription and illicit opioids remains at epidemic proportions, costing the United States billions of dollars annually. Overdose deaths in both the U.S. and Indiana have seen a dramatic increase over the past ten years. Until recently, prescription opioids were responsible for the greatest number of overdose deaths, but now have been surpassed by fatalities involving heroin and illicitly manufactured narcotics, primarily fentanyl.
- «
- 1 (current)
- 2
- 3
- »